Literature DB >> 6937945

Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects.

R Möllby, C E Nord, B Aronsson.   

Abstract

Over a 32-week period 1979, 256 fecal samples from 132 patients with antibiotic-associated enterocolitis were analyzed for the presence of C. difficile bacteria and/or toxin. The toxin test was positive in 35 patients (27%) and the bacterium was present in 14 patients (11%). Seventy-three patients with enterocolitis were investigated with regard to age, sex, antibiotic therapy, and clinical symptoms by analysis of their records. A positive toxin titre had an apparent predictive value of 69% for pseudomembranous enterocolitis or other serious colitis, while a negative titre had a 74% predictability for a non-serious disease. Many different types of antibiotics were found to be associated with enterocolitis. Incubation times of more than two weeks from the onset of the antibiotic therapy were noted in 12% of the cases. Vancomycin was administered orally in the treatment of 17 patients, with good results in all but two cases. Two case reports are presented in which relapses occurred upon renewed antibiotic treatment. It is concluded that routine diagnosis of C. difficile in faeces, especially through direct detection of toxin, may be useful in the clinical management of antibiotic-associated enterocolitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6937945

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  9 in total

1.  Identification of Clostridium difficile by detection of p-cresol in a cooked meat medium.

Authors:  T Navarro-Alonso; A Bernabeu-Esclapez; P L Valero-Guillén; F Martín-Luengo
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

Review 2.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

Review 4.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

6.  Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract.

Authors:  A Heimdahl; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

7.  Latex particle agglutination for detecting and identifying Clostridium difficile.

Authors:  R A Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

8.  Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

9.  Fusidic acid for the treatment of antibiotic-associated colitis induced by Clostridium difficile.

Authors:  S Cronberg; B Castor; A Thorén
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.